A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
What is the purpose of this trial?
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.
- Up to 1 Year
- Yale University
- September 2009
- Last Updated:
- June 23, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00974129